(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NOGRADERM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NOGRADERM

ST13

US500000079299987

Class

5, 42

Filing

79299987

Registration

6571416

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

06/06/2022

Trademark type

Combined

Nice classes

5, 42

Filing date

09/28/2020

Registration date

11/30/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/30/2021

Last transaction

11/30/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

IE

Examiner

REINHART, MEGHAN M

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Nogra Pharma Limited

Representatives

Michael A. Marrero Ulmer & Berne LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of immune-inflammatory mediated dermatological diseases and conditions such as acnepsoriasisskin diseases; medicated dermatological preparations; antibiotic dermatological products; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicated gels for dermatological use; medicated creams for dermatological use

Class 42

Research and development for the pharmaceutical industry; pharmaceutical research and development; pharmaceutical products development; consultancy relating to pharmaceutical research and development

Publications

History of USPTO decisions and trademark events.

21 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/06/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/17/2022

FIMP

FINAL DISPOSITION PROCESSED

05/17/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/28/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/30/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/14/2021

PUBO

PUBLISHED FOR OPPOSITION

09/14/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/26/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/10/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/22/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/21/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/21/2021

RFNT

REFUSAL PROCESSED BY IB

03/22/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/04/2021

RFRR

REFUSAL PROCESSED BY MPU

03/04/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/28/2021

CNRT

NON-FINAL ACTION WRITTEN

02/27/2021

DOCK

ASSIGNED TO EXAMINER

02/20/2021

MAFR

APPLICATION FILING RECEIPT MAILED

12/22/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/18/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/17/2020

Continuous trademark protection

Get notified about every new filing that threatens NOGRADERM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.